相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antiobesity Pharmacotherapy: New Drugs and Emerging Targets
G. W. Kim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Endocannabinoid-mediated retrograde modulation of synaptic transmission
Takako Ohno-Shosaku et al.
CURRENT OPINION IN NEUROBIOLOGY (2014)
The Endocannabinoid System - Back to the Scene of Cardiometabolic Risk Factors Control?
C. J. M. Martins et al.
HORMONE AND METABOLIC RESEARCH (2014)
High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes
Robert Brommage et al.
BONE RESEARCH (2014)
Improved glycemic control in mice lacking Sglt1 and Sglt2
David R. Powell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects
Tiziana Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation
Laura R. Pearce et al.
CELL (2013)
The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
Cristoforo Silvestri et al.
CELL METABOLISM (2013)
Modulating the endocannabinoid system in human health and disease successes and failures
Pal Pacher et al.
FEBS JOURNAL (2013)
Year in Diabetes 2012: The Diabetes Tsunami
R. Sherwin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
CBI RECEPTOR-DEFICIENT MICE AS A MODEL FOR DEPRESSION
O. Valverde et al.
NEUROSCIENCE (2012)
Postsynaptic diacylglycerol lipase α mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex
Hiroki Yoshino et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Depression-related anhedonic behaviors caused by immobilization stress: a comparison with nicotine-induced depression-like behavioral alterations and effects of nicotine and/or antidepressant drugs
Tamaki Hayase
JOURNAL OF TOXICOLOGICAL SCIENCES (2011)
Obesity 2 Health and economic burden of the projected obesity trends in the USA and the UK
Y. Claire Wang et al.
LANCET (2011)
Profound Obesity Secondary to Hyperphagia in Mice Lacking Kinase Suppressor of Ras 2
Jean-Pierre Revelli et al.
OBESITY (2011)
The Central Cannabinoid CB1 Receptor Is Required for Diet-Induced Obesity and Rimonabant's Antiobesity Effects in Mice
Zhen Pang et al.
OBESITY (2011)
Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice
Felipe V. Gomes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Rodent models in depression research: Classical strategies and new directions
Daniela D. Pollak et al.
ANNALS OF MEDICINE (2010)
CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance
Carmelo Quarta et al.
CELL METABOLISM (2010)
Effect of Rimonabant on Glycemic Control in Insulin-Treated Type 2 Diabetes: The ARPEGGIO Trial
Priscilla A. Hollander et al.
DIABETES CARE (2010)
Endocannabinoid biosynthesis and inactivation, from simple to complex
Giulio G. Muccioli
DRUG DISCOVERY TODAY (2010)
CB1 receptor deficiency decreases wheel-running activity: Consequences on emotional behaviours and hippocampal neurogenesis
Sarah Dubreucq et al.
EXPERIMENTAL NEUROLOGY (2010)
Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice
Ying Gao et al.
JOURNAL OF NEUROSCIENCE (2010)
Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo
Gabriel M. Simon et al.
MOLECULAR BIOSYSTEMS (2010)
Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
Abir T. El-Alfy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
Gunnar Thiemann et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways
Taku Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity
Carlos E. Leite et al.
PHARMACOLOGICAL REPORTS (2009)
The psychiatric side-effects of rimonabant
Fabricio A. Moreira et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2009)
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake
Carol Addy et al.
CELL METABOLISM (2008)
Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese patients Pooled 1-year data from the Rimonabant in Obesity (RIO) program
Luc Van Gaal et al.
DIABETES CARE (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes
Robert Brommage et al.
OBESITY (2008)
Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants
Katerina V. Savelieva et al.
PLOS ONE (2008)
CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors
Susana Mato et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in rodents
Tung M. Fong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice
Vladimir M. Pogorelov et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice
E Fride et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
YL Liu et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice
JF Cryan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
CR Trillou et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention
BP Zambrowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
CR Trillou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
ET Tzavara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
LP Shearman et al.
BEHAVIOURAL PHARMACOLOGY (2003)
Knockouts model the 100 best-selling drugs - Will they model the next 100?
BP Zambrowicz et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol
TC Kirkham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Cannabinoid receptors and their ligands
RG Pertwee et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
N Jamshidi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Leptin-regulated endocannabinoids are involved in maintaining food intake
V Di Marzo et al.
NATURE (2001)
分享论文
